NCT07824947

Brief Summary

The overall objective will be to observe whether a strength and balance training intervention produces significant changes in the analysis of double stance phase movement during gait, the analysis of coxofemoral, tibial and calcaneal joint movement during gait, pelvic floor contractile activity in standing and monopodal stability, stress urinary incontinence, fracture risk, sexual function and prolapse in sedentary menopausal women in the short and medium term.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2022

Completed
8 months until next milestone

Study Start

First participant enrolled

April 1, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
2.7 years until next milestone

First Posted

Study publicly available on registry

September 17, 2026

Completed
Last Updated

September 21, 2026

Status Verified

September 1, 2026

Enrollment Period

4 months

First QC Date

July 28, 2022

Last Update Submit

September 17, 2026

Conditions

Keywords

prolapseurinary incontinencegait disturbancegait analysissexual satisfactionrisk of fracture

Outcome Measures

Primary Outcomes (1)

  • Pelvic Floor Muscle Activity During Gait

    Mean root mean square (RMS) amplitude of the EMG signal of pelvic floor muscles recorded during 90 seconds of steady-state walking at self-selected speed using intracavitary electromyography (Mdurance®). Signals will be band-pass filtered (10-480 Hz), rectified, and processed using RMS.

    Baseline, Week 12 (post-intervention), Week 16 (1-month post-intervention), and Week 24 (3-months post-intervention)

Secondary Outcomes (2)

  • Gait Kinematics

    Baseline, Week 12 (post-intervention), Week 16 (1-month post-intervention), and Week 24 (3-months post-intervention)

  • Plantar Pressure Distribution

    Baseline, Week 12 (post-intervention), Week 16 (1-month post-intervention), and Week 24 (3-months post-intervention)

Study Arms (2)

Sequence A (Strength Training first)

EXPERIMENTAL

Participants will receive the strength training intervention (two 45-60 minute live online supervised sessions per week for 12 weeks) followed by a control/washout period.

Other: Strength training

Sequence B (Control first)

EXPERIMENTAL

Participants will first complete a control period (no training sessions) for 12 weeks, followed by the strength training intervention.

Other: Strength training

Interventions

Two 45-60 minute sessions per week for 12 weeks of live online training supervised by a qualified exercise specialist/physiotherapist.

Sequence A (Strength Training first)Sequence B (Control first)

Eligibility Criteria

Age45 Years - 77 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women aged 45 to 76 years.
  • Menopausal (minimum 12 months of amenorrhea).
  • Sedentary lifestyle (less than 30 minutes per day of regular exercise and less than 3 days per week according to WHO definition).
  • Availability to participate in the study and attend all scheduled sessions.
  • Able to read, write, and command spoken and written Spanish language.
  • Diagnosis of urinary incontinence, pelvic organ prolapse, and/or sexual dysfunction.

You may not qualify if:

  • Systemic disease.
  • Cardiovascular disease.
  • Vestibular and/or visual pathology (including vertigo, tinnitus, hypoacusis, or aural tinnitus).
  • History of psychiatric illness.
  • Cognitive deficits for any reason.
  • Neurological injury.
  • Use of walking aids, orthoses, or prostheses.
  • Ingestion of vestibular sedatives or central nervous system depressants.
  • Musculoskeletal diseases with lower limb deformity.
  • Lower limb surgery within the last 10 years.
  • Urogenital surgery.
  • Latex allergy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Europea de Madrid

Madrid, Villaviciosa de ODON, 28670, Spain

Location

MeSH Terms

Conditions

Gait Disorders, NeurologicPelvic Floor DisordersProlapseUrinary IncontinenceMobility LimitationOrgasm

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPregnancy ComplicationsMale Urogenital DiseasesPathological Conditions, AnatomicalUrination DisordersUrologic DiseasesLower Urinary Tract SymptomsUrological ManifestationsSexual BehaviorBehavior

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Masking Details
At the end of the PI's assessment, they will be contacted by researcher 1 who will randomly assign participants to either the intervention or control group.
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

July 28, 2022

First Posted

September 17, 2026

Study Start

April 1, 2023

Primary Completion

July 31, 2023

Study Completion

January 1, 2024

Last Updated

September 21, 2026

Record last verified: 2026-09

Locations